FGFR2 and metabolic dysfunction-associated steatotic liver disease: However, the NAFLD risk alleles FGFR2 rs9410328 and FGFR2 rs242041 (C and T alleles, respectively) did not significantly affect the expression of their corresponding genes in musculoskeletal and brain hypothalamus tissues, except for a marginal effect of rs9410328 in musculoskeletal tissue.